• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
375.784464
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
32.97
106132.35
EPS(TTM)
Face Value()
Div & Yield %
38.57
1
0.63
 

Citizen Infoline reports standalone net profit of Rs 14.02 crore in the March 2026 quarter
May 29,2026
Net profit of Citizen Infoline reported to Rs 14.02 crore in the quarter ended March 2026. There were no net profit/loss reported during the previous quarter ended March 2025. Sales rose 21854.00% to Rs 109.77 crore in the quarter ended March 2026 as against Rs 0.50 crore during the previous quarter ended March 2025.

For the full year,net profit rose 74666.67% to Rs 22.43 crore in the year ended March 2026 as against Rs 0.03 crore during the previous year ended March 2025. Sales rose 7577.04% to Rs 310.92 crore in the year ended March 2026 as against Rs 4.05 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales109.770.50 21854 310.924.05 7577
OPM %14.25-20.00 -10.71-8.15 -
PBDT16.450.01 164400 32.120.04 80200
PBT15.950.01 159400 30.120.04 75200
NP14.020 0 22.430.03 74667